We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECHO
1001
EchoStar
ECHO
$25.5B
| $630K | ﹤0.01% |
25,376
+6,660
| +36% | +$136K |
|
1002
NETSCOUT
NTCT
$2.86B
| $630K | ﹤0.01% |
28,952
+18,381
| +174% | +$362K |
|
1003
Wintrust Financial
WTFC
$10.7B
| $629K | ﹤0.01% |
5,798
+2,885
| +99% | +$301K |
|
1004
Sylvamo
SLVM
$1.52B
| $629K | ﹤0.01% |
7,324
-3,672
| -33% | -$274K |
|
|
XHR
1005
Xenia Hotels & Resorts
XHR
$1.98B
| $628K | ﹤0.01% |
42,546
+26,358
| +163% | +$366K |
|
1006
Graham Holdings Company
GHC
$4.97B
| $628K | ﹤0.01% |
764
+134
| +21% | +$102K |
|
1007
Cathay General Bancorp
CATY
$4.2B
| $626K | ﹤0.01% |
14,574
+3,800
| +35% | +$159K |
|
1008
Reinsurance Group of America
RGA
$15.7B
| $626K | ﹤0.01% |
2,871
-232
| -7% | -$49.3K |
|
1009
LCI Industries
LCII
$2.51B
| $625K | ﹤0.01% |
5,187
+1,366
| +36% | +$154K |
|
1010
Unifirst Corp
UNF
$5.32B
| $624K | ﹤0.01% |
3,141
-1,483
| -32% | -$273K |
|
1011
Agios Pharmaceuticals
AGIO
$2.16B
| $624K | ﹤0.01% |
14,042
+3,098
| +28% | +$141K |
|
1012
Dorman Products
DORM
$4.01B
| $621K | ﹤0.01% |
5,494
+1,407
| +34% | +$148K |
|
|
BWIN
1013
Baldwin Insurance Group
BWIN
$2.58B
| $620K | ﹤0.01% |
12,444
+4,373
| +54% | +$190K |
|
1014
Novavax
NVAX
$1.23B
| $618K | ﹤0.01% |
48,937
+12,330
| +34% | +$159K |
|
1015
Iovance Biotherapeutics
IOVA
$2.23B
| $618K | ﹤0.01% |
65,779
+16,718
| +34% | +$158K |
|
1016
Evolent Health
EVH
$475M
| $617K | ﹤0.01% |
21,815
+6,758
| +45% | +$174K |
|
1017
Patterson-UTI
PTEN
$3.87B
| $616K | ﹤0.01% |
80,567
+26,995
| +50% | +$249K |
|
1018
Genworth Financial
GNW
$3.8B
| $615K | ﹤0.01% |
89,846
+20,776
| +30% | +$137K |
|
1019
Gaming and Leisure Properties
GLPI
$12.8B
| $615K | ﹤0.01% |
11,961
-843
| -7% | -$41.8K |
|
1020
Helmerich & Payne
HP
$3.53B
| $615K | ﹤0.01% |
20,207
+5,184
| +35% | +$179K |
|
1021
Resideo Technologies
REZI
$5.23B
| $614K | ﹤0.01% |
30,480
+7,933
| +35% | +$157K |
|
1022
XPO
XPO
$25B
| $611K | ﹤0.01% |
5,687
-411
| -7% | -$46K |
|
1023
Diodes
DIOD
$4B
| $611K | ﹤0.01% |
9,532
+2,558
| +37% | +$177K |
|
1024
LXP Industrial Trust
LXP
$3.53B
| $610K | ﹤0.01% |
12,143
+3,200
| +36% | +$160K |
|
1025
Clear Secure
YOU
$5.26B
| $610K | ﹤0.01% |
18,403
+7,266
| +65% | +$187K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.